STRATATECH CORPORATION

Stratatech Corporation, a regenerative medicine company, engages in the development and commercialization of cell-based and tissue-engineered skin substitute products for therapeutic and research applications. The company specializes in human tissue substitutes generated with NIKS keratinocytes and cells derived from them for biological therapies. Its products include StrataGraft skin tissue, a temporary wound cover that promotes wound healing by the patient's own cells and improve the wound bed to receive autografts; and ExpressGraft skin tissue, a genetically enhanced tissue that produces various levels of natural wound healing and antimicrobial factors. The company was founded in 2000 and is based in Madison, Wisconsin.